Sunday, May 31, 2026

Experimental pill promises new hope for deadly pancreatic cancer

Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

SGX NIFTY

Loading...

Ads Inside Post